MDMA-assisted brief cognitive behavioral conjoint therapy for PTSD: Study protocol for a pilot study.
Leslie A. Morland, Dimitri Perivoliotis, Tamara R Wachsman, A Alam, Kayla Knopp, Chandra Khalifian, Dhakshin Ramanathan, Bettye E Chargin, Andrew W. Bismark, S Glynn, C Stauffer, A C Wagner
Contemporary Clinical Trials Communications August 1, 2024 DOI: 10.1016/j.conctc.2024.101314 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Single site, open-label study Pilot study Peer reviewed |
|---|---|
| Sample size | 16 |
| Population | U.S. military veterans with PTSD and their intimate partners |
| Interventions | MDMA-assisted therapy couple emotion focused integration sessions |
| Topics | MDMA PTSD |
| Keywords | Intimate relationships PTSD Treatment Couples therapy Psychedelic medicine Veterans mental health Trauma healing |
| Citations | 4 |
| Registration | NCT05979844 |
| Key points | This is a protocol description; no results are reported. |
Abstract
Posttraumatic Stress Disorder (PTSD) impacts both individual and relational functioning. Veteran couples are at increased risk of relationship distress due to military stressors such as deployment, family reintegration, and traumatic stress. Although both Cognitive-Behavioral Conjoint Therapy (CBCT) and its brief version (bCBCT) consistently have large effects on reducing PTSD symptoms, these treatments have more variable effects on relational outcomes. Given the impact of relationship functioning on the overall health of veterans, improving the effect of PTSD treatments on relationship functioning is an essential area of research. One promising path is the role of MDMA (3,4-methylenedioxymethamphetamine)-assisted therapy in augmenting the relational impact of established therapeutic interventions such as bCBCT. This is a single site, open-label study assessing the preliminary efficacy, safety, and acceptability of MDMA-assisted therapy in combination with bCBCT in 8 veterans with PTSD and their intimate partners (N = 16). Therapy teams trained in bCBCT and MDMA-assisted therapy will deliver bCBCT combined with two MDMA sessions and two couple emotion focused integration sessions. PTSD symptom severity and relationship functioning outcomes will be evaluated. This is the first study to examine the efficacy of MDMA-assisted bCBCT for improving PTSD and relationship functioning among a sample of U.S. military veterans and their partners. This project could provide an opportunity to pilot a scalable model of treating PTSD within the Veterans Affairs healthcare system and leverage the benefits of MDMA for veterans with PTSD, as well as the downstream benefits to their partner on both individual and relationship functioning. ClinicalTrials.gov Identifier: NCT05979844.
Comparable studies
Other non-randomized and open-label trials on MDMA for PTSD, most cited first.
Citations in the library
Cited by 4
- State of the Science: MDMA‐assisted psychotherapy for the treatment of posttraumatic stress disorder Journal of Traumatic Stress March 12, 2026
- Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting. Frontiers in Psychiatry 2025
- Prevalence of Potential Contraindications and Risk Factors Relevant to MDMA-Assisted Therapy Among U.S. Veterans with Posttraumatic Stress Disorder Journal of Psychoactive Drugs August 5, 2026
- Healing together: Results from a pilot trial of 3,4-Methylenedioxymethamphetamine-enhanced cognitive-behavioral conjoint therapy for posttraumatic stress disorder. Journal of Traumatic Stress September 4, 2026
Cites 7
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine October 1, 2023
- A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy Frontiers in Psychiatry March 20, 2019
- MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial. European Journal of Psychotraumatology December 7, 2020
- Methylenedioxymethamphetamine (MDMA) in Psychiatry Journal of Clinical Psychopharmacology October 10, 2018
and 2 more in the library